Progression-free survival (PFS) and overall survival (OS) in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC) treated with dostarlimab in the GARNET study

被引：2

作者：

Tinker, A. V. ^{[1
]}

Pothuri, B. ^{[2
]}

Gilbert, L. ^{[3
]}

Sabatier, R. ^{[4
]}

Brown, J. ^{[5
]}

Ghamande, S. ^{[6
]}

Mathews, C. ^{[7
]}

O'Malley, D. ^{[8
]}

Boni, V. ^{[9
]}

Gravina, A. ^{[10
]}

Banerjee, S. ^{[11
]}

Miller, R. ^{[12
]}

Pikiel, J. ^{[13
]}

Mirza, M. R. ^{[14
,15
]}

Duan, T. ^{[16
]}

Antony, G. ^{[17
]}

Zildjian, S. ^{[18
]}

Zografos, E. ^{[19
]}

Veneris, J. ^{[18
]}

Oaknin, A. ^{[20
]}

机构：

[1] Univ British Columbia, Dept Med, British Columbia Canc, Vancouver Ctr, Vancouver, BC, Canada

[2] Laura & Isaac Perlmutter Canc Ctr, Div Oncol, Dept Obstet & Gynecol, Gynecol Oncol Grp GOG, New York, NY USA

[3] McGill Univ Hlth Ctr, Gynecol Oncol, Montreal, PQ, Canada

[4] Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, Marseille, France

[5] Levine Canc Inst, Gynecol Oncol, Atrium Hlth, Charlotte, NC USA

[6] Augusta Univ, Georgia Canc Ctr, Obstetr & Gynecol, Augusta, GA USA

[7] Women & Infants Hosp Rhode Isl, Gynecol Oncol, Providence, RI USA

[8] Ohio State Univ & James Canc Ctr, Div Gynecol Oncol & Gynecol Oncol Phase Program, Columbus, OH USA

[9] NEXT Oncol Hosp Univ Quironsalud Madrid, Dept Oncol, Madrid, Spain

[10] Ist Nazl Tumori Fdn G Pascale, Clin Trial Unit, Oncol, Naples, Italy

[11] Royal Marsden NHS Fdn Trust & Inst Canc Res, Dept Gynaecol, London, England

[12] UCL, St Bartholomews Hosp London, Oncol, London, England

[13] Reg Ctr Oncol, Dept Chemotherapy, Gdansk, Poland

[14] Copenhagen Univ Hosp, Department Oncol, Rigshospitalet, Copenhagen, Denmark

[15] Nord Soc Gynaecol Oncologye Clin Trial Unit, Copenhagen, Denmark

[16] GlaxoSmithKline, Med Dev, Pennington, NJ USA

[17] GlaxoSmithKline, Med Dev, Brentford, England

[18] GlaxoSmithKline, Med Dev, Waltham, MA USA

[19] GlaxoSmithKline, Med Dev, London, England

[20] Hosp Univ Vall Hebron, Vall Hebron Barcelona Hosp Campus, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.676

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

548P

引用

页码：S798 / S799

页数：2